For patients diagnosed with IDH-mutant glioma, an incurable brain tumor that often affects adults in their 30s and 40s, treatment typically works at first. However, the cancer almost always returns, and when it does, it frequently stops responding to treatment.

There’s no doubt that advancements in surgical technology are changing lives, shifting care away from traditional open procedures toward less invasive, more precise techniques that promote faster healing and improved outcomes.

The U.S. Food and Drug Administration is announcing that it issued a “safe to proceed” letter to Revolution Medicines, allowing the sponsor to initiate an expanded access treatment protocol (EAP) for its experimental pancreatic cancer drug, daraxonrasib.

For the past 20 years, South Texas Health System Children’s has stood as a place where compassionate care and clinical excellence come together to create hope for children and their families.